These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 15948171)

  • 1. Screening and preventive behaviors one year after predictive genetic testing for hereditary nonpolyposis colorectal carcinoma.
    Collins V; Meiser B; Gaff C; St John DJ; Halliday J
    Cancer; 2005 Jul; 104(2):273-81. PubMed ID: 15948171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colon cancer screening practices following genetic testing for hereditary nonpolyposis colon cancer (HNPCC) mutations.
    Halbert CH; Lynch H; Lynch J; Main D; Kucharski S; Rustgi AK; Lerman C
    Arch Intern Med; 2004 Sep; 164(17):1881-7. PubMed ID: 15451763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colon cancer screening practices after genetic counseling and testing for hereditary nonpolyposis colorectal cancer.
    Hadley DW; Jenkins JF; Dimond E; de Carvalho M; Kirsch I; Palmer CG
    J Clin Oncol; 2004 Jan; 22(1):39-44. PubMed ID: 14701766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gynecologic cancer prevention in Lynch syndrome/hereditary nonpolyposis colorectal cancer families.
    Chen LM; Yang KY; Little SE; Cheung MK; Caughey AB
    Obstet Gynecol; 2007 Jul; 110(1):18-25. PubMed ID: 17601891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer.
    Gritz ER; Peterson SK; Vernon SW; Marani SK; Baile WF; Watts BG; Amos CI; Frazier ML; Lynch PM
    J Clin Oncol; 2005 Mar; 23(9):1902-10. PubMed ID: 15774782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance on mutation carriers of DNA mismatch repair genes.
    Järvinen HJ; Aarnio M
    Ann Chir Gynaecol; 2000; 89(3):207-10. PubMed ID: 11079789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of a decision aid for individuals considering genetic testing for hereditary nonpolyposis colorectal cancer risk.
    Wakefield CE; Meiser B; Homewood J; Ward R; O'Donnell S; Kirk J;
    Cancer; 2008 Sep; 113(5):956-65. PubMed ID: 18618513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
    Patient Educ Couns; 2007 Jan; 65(1):58-68. PubMed ID: 16872788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing.
    Lerman C; Hughes C; Croyle RT; Main D; Durham C; Snyder C; Bonney A; Lynch JF; Narod SA; Lynch HT
    Prev Med; 2000 Jul; 31(1):75-80. PubMed ID: 10896846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perceptions of cancer risks and predictors of colon and endometrial cancer screening in women undergoing genetic testing for Lynch syndrome.
    Hadley DW; Jenkins JF; Steinberg SM; Liewehr D; Moller S; Martin JC; Calzone KA; Soballe PW; Kirsch IR
    J Clin Oncol; 2008 Feb; 26(6):948-54. PubMed ID: 18281669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Family communication, genetic testing and colonoscopy screening in hereditary non-polyposis colon cancer: a qualitative study.
    McCann S; MacAuley D; Barnett Y; Bunting B; Bradley A; Jeffers L; Morrison PJ
    Psychooncology; 2009 Nov; 18(11):1208-15. PubMed ID: 19177338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention of colorectal cancer in families with hereditary nonpolyposis colorectal cancer].
    Bernstein IT; Bisgaard ML; Myrhøj T
    Ugeskr Laeger; 2003 Jan; 165(3):221-5. PubMed ID: 12555703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychological impact of genetic testing for hereditary non-polyposis colorectal cancer.
    Meiser B; Collins V; Warren R; Gaff C; St John DJ; Young MA; Harrop K; Brown J; Halliday J
    Clin Genet; 2004 Dec; 66(6):502-11. PubMed ID: 15521977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occult endometrial cancer and decision making for prophylactic hysterectomy in hereditary nonpolyposis colorectal cancer patients.
    Pistorius S; Kruger S; Hohl R; Plaschke J; Distler W; Saeger HD; Schackert HK
    Gynecol Oncol; 2006 Aug; 102(2):189-94. PubMed ID: 16476474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive testing for hereditary nonpolyposis colorectal cancer: subjective perception regarding colorectal and endometrial cancer, distress, and health-related behavior at one year post-test.
    Claes E; Denayer L; Evers-Kiebooms G; Boogaerts A; Philippe K; Tejpar S; Devriendt K; Legius E
    Genet Test; 2005; 9(1):54-65. PubMed ID: 15857188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer risk in young women at risk of hereditary nonpolyposis colorectal cancer: implications for gynecologic surveillance.
    Brown GJ; St John DJ; Macrae FA; Aittomäki K
    Gynecol Oncol; 2001 Mar; 80(3):346-9. PubMed ID: 11263929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study.
    van Oostrom I; Meijers-Heijboer H; Lodder LN; Duivenvoorden HJ; van Gool AR; Seynaeve C; van der Meer CA; Klijn JG; van Geel BN; Burger CW; Wladimiroff JW; Tibben A
    J Clin Oncol; 2003 Oct; 21(20):3867-74. PubMed ID: 14551306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attitudes toward colon cancer gene testing: factors predicting test uptake.
    Codori AM; Petersen GM; Miglioretti DL; Larkin EK; Bushey MT; Young C; Brensinger JD; Johnson K; Bacon JA; Booker SV
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):345-51. PubMed ID: 10207639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.
    Lancaster JM; Powell CB; Kauff ND; Cass I; Chen LM; Lu KH; Mutch DG; Berchuck A; Karlan BY; Herzog TJ;
    Gynecol Oncol; 2007 Nov; 107(2):159-62. PubMed ID: 17950381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening and prevention of hereditary gynecologic cancers.
    Kehoe SM; Kauff ND
    Semin Oncol; 2007 Oct; 34(5):406-10. PubMed ID: 17920895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.